# DESCRIPTION

## FIELD OF THE INVENTION

- relate to glioma therapy

## BACKGROUND OF THE INVENTION:

- introduce gliomas
- discuss prognosis of glioblastoma multiforme
- motivate PBEF1/NMPRTase as target for therapy
- discuss role of PBEF1 overexpression in glioma
- introduce FK866 as inhibitor of NMPRTase

## OBJECT OF THE INVENTION

- develop method for identifying compound for glioma therapy

## SUMMARY OF THE PRESENT INVENTION

- summarize method for identifying compound
- describe lead compound and its effects

## DETAILED DESCRIPTION OF THE PRESENT INVENTION

- introduce method of identifying compound useful as glioblastoma therapeutic agent
- outline steps of virtual screening of ligand library
- describe docking of dataset against NMPRTase
- identify possible compounds based on docked poses with binding energy lower than cut-off criteria
- experimentally test shortlisted compounds for inhibition of NMPRTase activity and growth of glioma cells
- identify 3-amino-2-benzyl-7-nitro-4-(2-quinolyl)-1,2-dihydro
- describe use of compound for Glioma therapy
- outline method for treating glioblastoma multiforme
- describe composition consisting of identified compound
- provide background information on NAD biosynthesis and NMPRTase

### EXAMPLE 1

- describe virtual screening method
- prepare ligand library and protein for docking
- perform docking using AutoDock
- shortlist potential leads based on docking results
- perform energy minimization using CNS software
- describe reagents and cell lines used
- outline RNA isolation and RT-qPCR method
- describe western blot analysis
- provide additional details on experimental methods

### EXAMPLE 2

- describe western blot analysis

### EXAMPLE 3

- describe NMPRTase assay

### EXAMPLE 4

- perform MTT assay

### EXAMPLE 5

- describe binding site

### EXAMPLE 6

- identify potential compounds
- analyze ligand protein contacts

### Inhibition of NMPRTase Activity by Selected Lead Compounds

- test inhibition of NMPRTase activity

### EXAMPLE 8

- test inhibition of cell growth

